Maribavir safety and efficacy for cytomegalovirus infections among transplant recipients
from 2 Minute Medicine
This phase 2, parallel-group randomized control trial compared the safety and efficacy profile of maribavir versus valgancicvlovir among patients who received solid organ transplants, finding that both medications had comparable efficacy profiles in preventing CMV infection within six weeks of starting therapy.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063